Halcyon Molecular Quietly Shuts Down Sequencing Operation
August 20, 2012
August 20, 2012 | Halcyon Molecular, one of the many companies that was working on next-generation DNA sequencing technologies, has quietly ceased operations due to a shortage of funds, GigaOM reports. The company, advised by Harvard Medical School's George Church, had raised upwards of $20 million in funding from Founders Fund, Elon Musk and others. GigaOM
